Skip to main content
Figure 3 | Arthritis Research & Therapy

Figure 3

From: Significant effects of biologic therapy on lipid profiles and insulin resistance in patients with rheumatoid arthritis

Figure 3

Change in lipid profiles, AI, mFRS, and IR after therapy with or without biologics. (A1) The changes in serum levels of lipid profile after 6 months of therapy in adalimumab-treated patients. (A2) The changes in AI, mFRS, and IR after 6 months of therapy in adalimumab-treated patients. (B1) The changes in serum levels of lipid profile after 6 months of therapy in etanercept-treated patients. (B2) The changes in AI, mFRS, and IR after 6 months of therapy in etanercept-treated patients. (C1) The changes in serum levels of lipid profile after 6 months of therapy in tocilizumab-treated patients. (C2) The changes in AI, mFRS, and IR after 6 months of therapy in tocilizumab-treated patients. (D1) The changes in serum levels of lipid profile after 6 months treatment in biologic-naïve patients. (D2) The changes in AI, mFRS, and IR after 6 months treatment in biologic-naïve patients.

Back to article page